Short answer · Medically reviewed summary · Last updated: 2026-04-07
Goodpasture syndrome is primarily known as anti-glomerular basement membrane (anti-GBM) disease in modern clinical literature, though it is also historically referred to as Goodpasture's disease. These terms describe the same autoimmune condition characterized by the presence of autoantibodies against the alpha-3 chain of type IV collagen in the kidneys and lungs. What are the historical and alternative names for Goodpasture syndrome? The condition was named after Dr.
Goodpasture syndrome is primarily known as anti-glomerular basement membrane (anti-GBM) disease in modern clinical literature, though it is also historically referred to as Goodpasture's disease. These terms describe the same autoimmune condition characterized by the presence of autoantibodies against the alpha-3 chain of type IV collagen in the kidneys and lungs.
The condition was named after Dr. Ernest Goodpasture, who first described the clinical association between pulmonary hemorrhage and glomerulonephritis in 1919. While Goodpasture syndrome remains the most common term used by patients and in general medical discourse, the nomenclature has evolved as our understanding of the underlying pathophysiology has improved. Historical literature may also refer to the condition as "Goodpasture's disease" or "Goodpasture's nephritis." Because the disease involves the production of specific autoantibodies, medical professionals increasingly prefer the more precise term anti-GBM disease to describe the underlying immunologic mechanism.
The use of multiple terms for Goodpasture syndrome stems from the transition from eponyms (names based on the physician who described the case) to descriptive, mechanism-based terminology. In the early 20th century, naming diseases after the reporting physician was standard practice. However, as medical science identified that the primary driver of Goodpasture syndrome is the formation of anti-glomerular basement membrane antibodies, researchers adopted "anti-GBM disease" to better reflect the clinical reality. This shift helps clinicians and patients distinguish the specific autoimmune process from other types of vasculitis or renal-pulmonary syndromes.
In global medical coding and research databases, the condition is categorized to ensure consistency across international health systems. Understanding these classifications can help patients when reviewing their own medical records or searching global research databases:
If you are searching for information, it is helpful to use both "Goodpasture syndrome" and "anti-GBM disease" in your queries to capture the widest range of academic and patient-focused resources. At DiseaseMaps.org, where 108 members have shared their journeys with Goodpasture syndrome, you will find that the community often uses these terms interchangeably. When speaking with your nephrologist or rheumatologist, asking if your diagnosis is specifically "anti-GBM disease" can clarify that your treatment plan is focused on the rapid removal or suppression of the specific autoantibodies responsible for Goodpasture syndrome.
Medical disclaimer: This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.